All In MedTech

Device Trial Radar · NCT03038438

ABRE Clinical Study of the Abre Venous Self-expanding Stent System

A Multi-center, Non-randomized Study to Evaluate the Safety and Effectiveness of the Abre Venous Self-expanding Stent System in Patients With Symptomatic Iliofemoral Venous Outflow Obstruction

Last checked: Nov 20, 2026Latest source record: Nov 8, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

260

Actual

Start

Dec 13, 2017

Primary completion

Jan 14, 2020

Study completion Jan 28, 2022

Sponsor

Lead sponsor
Medtronic EndovascularPublic (MDT)
Sponsor type
Industry
First posted
Jan 31, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Evaluate the safety and effectiveness of the Abre venous self-expanding stent system for treatment of symptomatic iliofemoral venous outflow obstruction in patients with venous occlusive disease.

Conditions

  • Iliofemoral Venous Obstruction

Interventions

  • Abre venous self-expanding stent systemDevice

    venous stent

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary PatencyTime frame: 12 Months
  2. Composite Major Adverse EventsTime frame: 30 Days

Locations

24 sites in 6 countries. Site status is shown where the registry gives one.

  • St. Joseph Hospital

    Orange, California

  • The Vascular Experts

    Darien, Connecticut

  • Piedmont Atlanta Hospital

    Atlanta, Georgia

21 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.